ROCHE HOLDING LTD (RHHBY)
Clinical trial NCT03448042 updates: 1. completion date: 2026-11-30 → 2027-11-30 2. primary completion date: 2026-11-30 → 2027-11-30 3. enrollment: not set → 123 participants
Clinical trial NCT03448042 updates: 1. completion date: 2026-11-30 → 2027-11-30 2. primary completion date: 2026-11-30 → 2027-11-30 3. enrollment: not set → 123 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical